20 days ago
BLLN
AnalystsSubbu NambiSubbu Nambi's Stock Forecasts
AnalystsSubbu Nambi
Analyst Ranking
Top 2%
#72 out of 5288 analysts
Average Return
+104.05%
Win Rate
62%45 out of 73
Risk vs Reward
Poor
Good
Subbu Nambi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +4,095.93% | $44.45 | $1,865.09 | 2025-04-10 - 2026-03-24 | Strong Buy |
Exact Sciences CorpEXAS | +2,580.11% | $69.59 | $1,865.09 | 2025-11-03 - 2026-03-24 | Strong Buy |
Natera IncNTRA | +176.34% | $60.27 | $166.55 | 2023-12-13 - 2024-12-13 | Strong Buy |
Guardant Health IncGH | +122.48% | $42.44 | $94.42 | 2025-02-23 - 2026-02-23 | Strong Buy |
Guardant Health IncGH | +114.59% | $60.18 | $129.14 | 2025-09-24 - 2026-06-01 | Strong Buy |
Subbu Nambi Analyst Color
Get additional color on Subbu Nambi's coverage of popular stocks
a month ago
TWST
a month ago
CYRX
2 months ago
TWST
3 months ago
NAUT
4 months ago
TWST
4 months ago
SOPH
4 months ago
PSNL
4 months ago
GRAL
4 months ago
GH
4 months ago
CSTL
4 months ago
ADPT
5 months ago
VCYT
5 months ago
NTRA
5 months ago
GH
5 months ago
DHR
5 months ago
CSTL
7 months ago
PSNL
7 months ago
WGS
8 months ago
TEM
8 months ago
GH
a year ago
TEM
Subbu Nambi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Illumina IncILMN | 6 | Strong Buy | $180.00 | +9.49% | Maintains | a day ago |
Billiontoone IncBLLN | 3 | Strong Buy | $120.00 | +31.69% | Maintains | 20 days ago |
Adaptive Biotechnologies CorpADPT | 3 | Strong Buy | $21.00 | +37.89% | Reiterates | a month ago |
Twist Bioscience CorpTWST | 5 | Strong Buy | $60.00 | -11.58% | Maintains | a month ago |
Cryoport IncCYRX | 2 | Strong Buy | $12.00 | -24.95% | Maintains | a month ago |
Genedx Holdings CorpWGS | 4 | Strong Buy | $70.00 | +34.62% | Maintains | a month ago |
Danaher CorpDHR | 4 | Strong Buy | $235.00 | +30.65% | Maintains | a month ago |
Bruker CorpBRKR | 4 | Strong Buy | $50.00 | -14.44% | Maintains | 2 months ago |
Grail IncGRAL | 3 | Strong Buy | $75.00 | +16.46% | Maintains | 2 months ago |
Tempus Ai IncTEM | 4 | Strong Buy | $60.00 | +13.64% | Maintains | 2 months ago |
Veracyte IncVCYT | 6 | Strong Buy | $45.00 | -6.60% | Maintains | 2 months ago |
Nautilus Biotechnology IncNAUT | 2 | Strong Buy | $4.00 | +44.40% | Maintains | 3 months ago |
Waters CorpWAT | 1 | Strong Buy | $440.00 | +16.35% | Reiterates | 4 months ago |
Sophia Genetics SaSOPH | 2 | Strong Buy | $7.00 | +40.28% | Maintains | 4 months ago |
Personalis IncPSNL | 2 | Strong Buy | $13.00 | +15.45% | Maintains | 4 months ago |
Guardant Health IncGH | 5 | Strong Buy | $135.00 | +4.54% | Maintains | 4 months ago |
Castle Biosciences IncCSTL | 3 | Strong Buy | $47.00 | +124.13% | Maintains | 4 months ago |
Neogen CorpNEOG | 4 | Strong Buy | $12.00 | +34.53% | Maintains | 5 months ago |
Natera IncNTRA | 3 | Strong Buy | $270.00 | +23.39% | Maintains | 5 months ago |
Exact Sciences CorpEXAS | 3 | Strong Buy | $75.00 | -95.98% | Maintains | 7 months ago |
Caris Life Sciences IncCAI | 2 | Strong Buy | $36.00 | +118.84% | Maintains | 10 months ago |
Myriad Genetics IncMYGN | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
10x Genomics IncTXG | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.